Humira and Paricalcitol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humira (adalimumab) and Paricalcitol (paricalcitol). Common drug interactions include atrial fibrillation among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Humira and Paricalcitol. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.

What is Paricalcitol?

Paricalcitol has active ingredients of paricalcitol. eHealthMe is studying from 1,278 Paricalcitol users. Check the latest studies of Paricalcitol.

On Jul, 06, 2026

13 people who take Humira and Paricalcitol together, and have interactions are studied.

Humira and Paricalcitol drug interactions.

What are the common drug interactions of Humira and Paricalcitol, by gender? *:

female:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Chronic kidney disease
Headache (pain in head)
Hypertension (high blood pressure)
Influenza
Pericardial effusion (fluid around the heart)
Pleural effusion (water on the lungs)
Pneumonia
Blood phosphorus increased
Blood potassium increased

male:

Blood creatinine increased
Blood potassium decreased
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Glossodynia (a burning or painful sensation in the tongue)
Helicobacter gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium)
Injection site bruising
Oral candidiasis (fungal infection of mouth)
Oxygen saturation decreased
Pneumonia
Rash erythematous (redness of the skin)

What are the common drug interactions of Humira and Paricalcitol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dyspepsia (indigestion)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Helicobacter gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium)
Rash erythematous (redness of the skin)
Rash pruritic (redness with itching)
Renal disorder (kidney disease)
Renal failure (kidney dysfunction)

50-59:

n/a

60+:

Pneumonia
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood potassium increased
Blood pressure inadequately controlled
Glossodynia (a burning or painful sensation in the tongue)
Oedema peripheral (superficial swelling)
Oxygen saturation decreased
Renal impairment (severely reduced kidney function)
Skin ulcer
Chronic kidney disease

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 30.77%
High Blood Pressure: 3 people, 23.08%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 15.38%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 15.38%
Pain: 2 people, 15.38%
Neuropathy Peripheral (surface nerve damage): 2 people, 15.38%
Renal Disorder (kidney disease): 2 people, 15.38%
High Blood Cholesterol: 1 person, 7.69%
Bone Disorder: 1 person, 7.69%
Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Humira and Paricalcitol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously